HIV-host interactions: A map of viral perturbation of the host system

AIDS

Volumn 23, Issue 5, 2009, Pages 549-554

  Pinney, John W ^a,d   Dickerson, Jonathan E ^a   Fu, William ^b   Sanders Beer, Brigitte E ^c   Ptak, Roger G ^b   Robertson, David L ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b SOUTHERN RESEARCH INSTITUTE   (United States)

^c BIOQUAL INC   (United States)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

AIDS; HIV; Host; Interaction; Map; Network; Pathogen

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CELL PROTEIN; DNA; ENFUVIRTIDE; GENE PRODUCT; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MARAVIROC; MESSENGER RNA; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RN 18; UNCLASSIFIED DRUG; VIF PROTEIN; VIRUS PROTEIN; VPU PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DISEASE COURSE; DRUG TARGETING; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; MEDICAL RESEARCH; NONHUMAN; NOTE; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS LOAD; VIRUS MUTATION; VIRUS REPLICATION;

ANTI-HIV AGENTS; COMPUTATIONAL BIOLOGY; GENES, VIRAL; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; PROTEIN BINDING;

EID: 63149177869     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328325a495     Document Type: Note

References (38)

1. Peterlin BM, Trono D. Hide, shield and strike back: how HIV-infected cells avoid immune eradication. Nat Rev Immunol 2003; 3:97-107.
2. Heeney JL, Dalgleish AG, Weiss RA. Origins of HIV and the evolution of resistance to AIDS. Science 2006; 313:462-466.
3. Goff SP. Host factors exploited by retroviruses. Nat Rev Microbiol 2007; 5:253-263.
4. Gao F, Bailes E, Robertson DL, Chen Y, Rodenburg CM, Michael SF, et al. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 1999; 397:436-441.
5. Gougeon ML. Apoptosis as an HIV strategy to escape immune attack. Nat Rev Immunol 2003; 3:392-404.
6. Ptak RG, Fu W, Sanders-Beer BE, Dickerson JE, Pinney JW, Robertson DL, et al. Cataloguing the HIV-1 Human Protein Interaction Network. AIDS Research and Human Retroviruses 2008; 24:1497-1502.
7. Fu W, Sanders-Beer BE, Katz KS, Maglott DR, Pruitt KD, Ptak RG. Human immunodeficiency virus type 1, human protein interaction database at NCBI. Nucleic Acids Res 2009; 37:D417-D422.
8. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat Genet 2000; 25:25-29.
9. Dyer MD, Murali TM, Sobral BW. The landscape of human proteins interacting with viruses and other pathogens. PLoS Pathog 2008; 4:e32.
10. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, Xavier RJ, et al. Identification of host proteins required for HIV infection through a functional genomic screen. Science 2008; 319:921-926.
11. Konig R, Zhou Y, Elleder D, Diamond TL, Bonamy GM, Irelan JT, et al. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 2008; 135:49-60.
12. Bandyopadhyay S, Kelley R, Ideker T. Discovering regulated networks during HIV-1 latency and reactivation. Pacific Symposium on Biocomputing 2006; 11:354-366.
13. Kwoh CK, Ng PY. Network analysis approach for biology. Cell Mol Life Sci 2007; 64:1739-1751.
14. Aittokallio T, Schwikowski B. Graph-based methods for analysing networks in cell biology. Brief Bioinformatics 2006; 7:243-255.
15. Nikolsky Y, Nikolskaya T, Bugrim A. Biological networks and analysis of experimental data in drug discovery. Drug Discov Today 2005; 10:653-662.
16. Baitaluk M, Sedova M, Ray A, Gupta A. Biological networks: visualization and analysis tool for systems biology. Nucleic Acids Res 2006; 34:W466-471.
17. Butcher E, Berg E, Kunkel E. Systems biology in drug discovery. Nat Biotech 2004; 22:1253-1259.
18. Materi W, Wishart D. Computational systems biology in drug discovery and development: methods and applications. Drug Discovery Today 2007; 12:295-303.
19. Kellam P. Attacking pathogens through their hosts. Genome Biol 2006; 7:201.
20. Dorr P, Westby M, Dobbs S, Griffin P, Irvine B, Macartney M, et al. Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum antihuman immunodeficiency virus type 1 activity. Antimicrob Agents Chemother 2005; 49:4721-4732.
21. Lalezari JP, Eron JJ, Carlson M, Cohen C, DeJesus E, Arduino RC, et al. A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy. AIDS 2003; 17:691-698.
22. Hopkins AL. Network pharmacology. Nat Biotechnol 2007; 25:1110-1111.
23. Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, et al. Drug bank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res 2008; 36:D901-906.
24. Zimmermann G, Lehar J, Keith C. Multitarget therapeutics: when the whole is greater than the sum of the parts. Drug Discovery Today 2007; 12:34-42.
25. del Real G, Jiménez-Baranda S, Mira E, Lacalle RA, Lucas P, Gómez-Moutón C, et al. Statins inhibit HIV-1 infection by down-regulating Rho activity. J Exp Med 2004; 200:541-547.
26. Sheehy AM, Gaddis NC, Choi JD, Malim MH. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 2002; 418:646-650.
27. Neil SJ, Zang T, Bieniasz PD. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008; 451:425-430.
28. Wiegand HL, Doehle BP, Bogerd HP, Cullen BR. A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins. Embo J 2004; 23:2451 2458.
29. Nathans R, Cao H, Sharova N, Ali A, Sharkey M, Stranska R, et al. Small-molecule inhibition of HIV-1 Vif. Nat Biotechnol 2008; 26:1187-1192.
30. Paolini G, Shapland R, Van Hoorn W, Mason J, Hopkins A. Global mapping of pharmacological space. Nat Biotechnol 2006; 24:805-815.
31. Hajduk PJ, Huth JR, Tse C. Predicting protein druggability. Drug Discovery Today 2005; 10:1675-1682.
32. Goh K, Cusick M, Valle D, Childs B, Vidal M, Barabási A. The human disease network. Proc Natl Acad Sci USA 2007; 104:8685-8690.
33. Telenti A, Goldstein DB. Genomics meets HIV-1. Nat Rev Microbiol 2006; 4:865-873.
34. Hutcheson HB, Lautenberger JA, Nelson GW, Pontius JU, Kessing BD, Winkler CA, et al. Detecting AIDS restriction genes: From candidate genes to genome-wide association discovery. Vaccine 2008; 26:2951-2965.
35. Fellay J, Shianna K, Ge D, Colombo S, Ledergerber B, Weale M, et al. A whole-genome association study of major determinants for host control of HIV-1. Science 2007; 317:944-947.
36. Hakes L, Pinney JW, Lovell SC, Oliver SG, Robertson DL. All duplicates are not equal: the difference between small-scale and genome duplication. Genome Biol 2007; 8:R209.
37. Jiang JJ, Conrath DW. Semantic similarity based on corpus statistics and lexical taxonomy. Proceedings of International Conference on Research in Computational Linguistics (ROCLING X) 1997.
38. Adai AT, Date SV, Wieland S, Marcotte EM. LGL: creating a map of protein function with an algorithm for visualizing very large biological networks. J Mol Biol 2004; 340:179-190.